in

Settlement reached in RoundUp cancer lawsuits

The litigation of thousands of RoundUp cancer cases is about to be completed as Bayer, the owner of Monsanto, has decided to settle all of the lawsuits to the tune of $10.5 billion (USD).  With an estimated case count being around 100,000, that means that each litigant will receive around an average of $105,000 (USD).

These cases were filed against Monsanto and Bayer because consumers contracted non-Hodgkins lymphoma (NHL) from spraying RoundUp on their lawns.  The caveat for Bayer in the settlement is that the pharmaceutical giant will not be compelled to admit any wrongdoing.  That means that nobody else will be able to file a future lawsuit against the company when they obtain cancer from using the product.  RoundUp products will remain on shelves throughout the USA.

Another result in the settlement means that farmers can continue to use GMO seeds that are resistant to glyphosate, the active ingredient in the weedkiller.  Thus, glyphosate will still be in foods that contain corn and soybeans.

Report

What do you think?

Legend

Written by ahol888

Coolest dwarf in the world. Expert on the topic of mediocrity.

2 Comments

Leave a Reply

Leave a Reply